News from cmc biologics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

08 Jan, 2018, 16:00 GMT AGC Bioscience, Biomeva, and CMC Biologics to provide services under the brand AGC Biologics

AGC Biologics, a convergence of Asahi Glass Company (AGC) Bioscience, Biomeva GmbH, and CMC Biologics, announced today that effective January 8,...


12 Dec, 2017, 15:00 GMT CMC Biologics Announces Development and Manufacturing Agreement with Harpoon Therapeutics

CMC ICOS Biologics, Inc. ("CMC Biologics"), a global leader in clinical and commercial manufacturing of therapeutic proteins, and Harpoon...


13 Oct, 2016, 07:40 BST Through their PROVEO™ Partnership, CMC Biologics and IDT Biologika Announce the Addition of Cerbios-Pharma and Oncotec Pharma to their Strategic Collaboration for Manufacture of Antibody Drug Conjugates

CMC Biologics A/S, a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, and IDT...


15 Jun, 2016, 06:53 BST CMC Biologics Cleared for Commercial Manufacture of CSL Behring's FDA-Approved AFSTYLA®

CMC Biologics, a global leader in clinical and commercial manufacturing of monoclonal antibodies, coagulation factors and other therapeutic proteins, ...


02 Jun, 2016, 11:55 BST CMC Biologics Expands GMP Manufacturing Capacity in Europe

CMC Biologics, a global leader in clinical and commercial manufacturing of monoclonal antibodies, coagulation factors and other therapeutic proteins, ...


29 Mar, 2016, 10:00 BST CMC Biologics Recognized as a Leader in Contract Development and Manufacturing by Customers and the Biopharmaceutical Industry

CMC Biologics, a world leader in contract development and manufacturing of therapeutic proteins, today announced its recognition by Life Science...


29 Jul, 2015, 11:00 BST CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy

CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River...


16 Dec, 2014, 12:00 GMT CMC Biologics and OncoSynergy Enter into an Agreement for Accelerated Process Development and GMP Manufacture of an Investigational Drug to Combat Ebola

CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for...


06 May, 2014, 10:00 BST CMC Biologics and MacroGenics Enter into a Process Development and Manufacturing Agreement for Oncology Product Candidate

CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage...


02 Apr, 2014, 19:23 BST CMC Biologics Wins 2014 CMO Leadership Awards for Innovation, Quality and Reliability

CMC Biologics, a leading global contract manufacturing organization known for technical excellence and customer satisfaction in biopharmaceutical...


08 Jan, 2014, 04:50 GMT Jesper Bramming, former A.P. Moller Executive, Joins the CMC Biologics Executive Management Team as Chief Financial Officer

CMC Biologics, a leading biopharmaceutical process development and biopharmaceutical manufacturing organization, announced today that it has...


03 Dec, 2013, 05:00 GMT CMC Biologics Enters into Agreement with the University of Copenhagen for Development and Clinical Manufacture of Placental Malaria Vaccine

CMC Biologics, known for its technical excellence in process development and cGMP manufacture of protein therapeutics, announced that earlier this...


15 Oct, 2013, 06:11 BST CMC Biologics Achieves Authorization for cGMP Commercial Manufacturing by the Danish Medicines Agency

CMC Biologics has received renewal of its manufacturing and importation authorization (MIA) for Good Manufacturing Practice (cGMP) production of...


19 Mar, 2013, 11:00 GMT CMC Biologics Wins 2013 CMO Leadership Award for Innovation, Quality and Reliability

CMC Biologics, a global contract manufacturing organization known for its technical excellence in biopharmaceutical development and cGMP manufacture...


12 Sep, 2012, 09:00 BST CMC Biologics Establishes Commercial Presence in Japan through Strategic Agreement with Innomedica

CMC Biologics, a leading contract manufacturing organization known for its technical excellence in process development and cGMP manufacture, and...


10 Sep, 2012, 10:00 BST CMC Biologics Announces Mark W. Sawicki as Vice President, Global Business Development

CMC Biologics, a leading contract manufacturing organization known for its technical excellence in process development and cGMP manufacture,...


30 Aug, 2012, 17:42 BST CMC Biologics Announces New General Manager of Copenhagen Facility

CMC Biologics, a leading contract manufacturing organization known for its technical excellence in process development and cGMP manufacture, today...


17 Apr, 2012, 01:55 BST CMC Biologics Highlights Technical Acumen at Upcoming Conferences

CMC Biologics is a leading contract manufacturing organization (CMO) known and respected for its technical excellence in process development and cGMP ...


05 Jan, 2012, 13:00 GMT CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems

CMC Biologics, a leading biopharmaceutical contract manufacturing organization, announced the issuance of European Patent No. US 2,171,034 B1...


09 Nov, 2011, 15:00 GMT CMC Biologics, Thermo Fisher Scientific, Applikon Biotechnology and BioProcess International Highlight Industry and Academic Expertise at Pharmaceutical Manufacture Seminar on Single-Use Technology

Single-use technologies are widely accepted in the biomanufacturing of biological therapeutics and vaccines. Pharma/biopharmaceutical companies,...


26 Oct, 2011, 15:00 BST CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies

CMC Biologics today announced the execution of an agreement with Daiichi Sankyo Co., Ltd. ('Daiichi Sankyo') to provide process development support...


20 Sep, 2011, 15:00 BST CMC Biologics Enters Commercial Supply Agreement with Inspiration Biopharmaceuticals for IB1001

CMC Biologics and Inspiration Biopharmaceuticals ("Inspiration") today announced that the two companies have entered into a long-term commercial...


07 Sep, 2011, 15:00 BST CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics

CMC Biologics and Oxford BioTherapeutics (OBT) today announced that they have entered into a non-exclusive license agreement providing OBT with...


01 Sep, 2011, 15:30 BST CMC Biologics Adds 2,000 Liter Single-Use Bioreactor at its Copenhagen Manufacturing Facility

- Several planned events highlight CMC Biologics' expertise in single-use technology CMC Biologics today announced the completion of the installation ...


22 Jun, 2011, 15:30 BST CMC Biologics Expands Its Production Facility and Rebrands Its Corporate Identity

CMC Biologics today announced that it is in the final stages of expanding its stainless steel biopharmaceutical production facility at its Bothell...